Susceptibility locus in neurokinin-1 receptor gene associated with alcohol dependence

Neuropsychopharmacology

Volumn 34, Issue 11, 2009, Pages 2442-2449

  Seneviratne, Chamindi ^a   Ait Daoud, Nassima ^a   Ma, Jennie Z ^b   Chen, Guobo ^a,c   Johnson, Bankole A ^a   Li, Ming D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Addiction; Alcohol dependence; Association; NK1R; SNPs

Indexed keywords

NEUROKININ 1 RECEPTOR;

3' UNTRANSLATED REGION; ADULT; ALCOHOLISM; ARTICLE; BRAIN; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

ALCOHOLISM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NEUROKININ-1; SEQUENCE ANALYSIS, DNA;

EID: 70349098709     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.65     Document Type: Article

References (34)

1. Almeida TA, Rojo J, Nieto PM, Pinto FM, Hernandez M, Martin JD et al (2004). Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 11: 2045-2081. (Pubitemid 38967729)
2. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC.
3. Babor TF, de la Fuente JR, Saunders J, Grant M (1992). AUDIT: The Alcohol Use Disorders Identification Test. World health organization: Geneva, Switzerland.
4. Beuten J, Ma JZ, Payne TJ, Dupont RT, Crews KM, Somes G et al (2005). Single- and multilocus allelic variants within the GABAB receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am J Hum Genet 76: 859-864.
5. Caberlotto L, Hurd YL, Murdock P, Wahlin JP, Melotto S, Corsi M et al (2003). Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain. Eur J Neurosci 17: 1736-1746.
6. Dudbridge F (2008). Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66: 87-98.
7. First MB, Spitzer RL, Gibbon M, Williams JBW (1994). Structured Clinical Interview for DSM-IV Axis I DisordersFPatient Edition (SCID-I/P version 2.0). New York State Psychiatric Institute, Biometrics Research Department: New York.
8. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al (2002). The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
9. Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL et al (2005). Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 293: 1617-1625.
10. George DT, Gilman J, Hersh J, Thorsell A, Herion D, Geyer C et al (2008). Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 319: 1536-1539.
11. Giegling I, Rujescu D, Mandelli L, Schneider B, Hartmann AM, Schnabel A et al (2007). Tachykinin receptor 1 variants associated with aggression in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 144B: 757-761.
12. Goodman A (2008). Neurobiology of addiction. An integrative review. Biochem Pharmacol 75: 266-322.
13. Hodges LM, Weissman MM, Haghighi F, Costa R, Bravo O, Evgrafov O et al (2009). Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder. Am J Med Genet B Neuropsychiatr Genet 150B: 65-73.
14. Holmes A, Heilig M, Rupniak NM, Steckler T, Griebel G (2003) Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24: 580-588.
15. Johnson BA (2008). Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol 75: 34-56.
16. Kosoy R, Nassir R, Tian C, White PA, Butler LM, Silva G et al (2008). Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in america. Hum Mutat 30: 69-78.
17. Lai JP, Cnaan A, Zhao H, Douglas SD (2008). Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions. J Neurosci Methods 168: 127-133.
18. Lequin O, Bolbach G, Frank F, Convert O, Girault-Lagrange S, Chassaing G et al (2002). Involvement of the second extracellular loop (E2) of the neurokinin-1 receptor in the binding of substance P. Photoaffinity labeling and modeling studies. J Biol Chem 277: 22386-22394.
19. Li MD, Payne TJ, Ma JZ, Lou XY, Zhang D, Dupont RT et al (2006). A genomewide search finds major susceptibility loci for nicotine dependence on chromosome 10 in African Americans. Am J Hum Genet 79: 745-751.
20. Mao X, Bigham AW, Mei R, Gutierrez G, Weiss KM, Brutsaert TD et al (2007). A genomewide admixture mapping panel for Hispanic/Latino populations. Am J Hum Genet 80: 1171-1178.
21. Marui T, Funatogawa I, Koishi S, Yamamoto K, Matsumoto H, Hashimoto O et al (2007). Tachykinin 1 (TAC1) gene SNPs and haplotypes with autism: a case-control study. Brain Dev 29: 510-513.
22. Nikolaev SV, Bychkov ER, Lebedev AA, Dambinova SA (2003). Mechanisms of the influences of the central administration of substance P on ethanol consumption in chronically alcoholic rats. Neurosci Behav Physiol 33: 905-909.
23. Nyholt DR (2004). A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74: 765-769.
24. Perlis RH, Purcell S, Fagerness J, Kirby A, Petryshen TL, Fan J et al (2008). Family-based association study of lithium-related and other candidate genes in bipolar disorder. Arch Gen Psychiatry 65 : 53-61.
25. Peyrard-Janvid M, Anthoni H, Onkamo P, Lahermo P, Zucchelli M, Kaminen N et al (2004). Fine mapping of the 2p11 dyslexia locus and exclusion of TACR1 as a candidate gene. Hum Genet 114: 510-516.
26. Randolph GP, Simon JS, Arreaza MG, Qiu P, Lachowicz JE, Duffy RA (2004). Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variant. Pharmacogenomics J 4: 394-402.
27. Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R et al (2001). Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98: 1912-1917.
28. SAS Institute Inc (2003). SAS Version 9.1. SAS Institute Inc.: Cary, NC.
29. Sinha R, Robinson J, O'Malley S (1998). Stress response dampening: effects of gender and family history of alcoholism and anxiety disorders. Psychopharmacology (Berl) 137: 311-320.
30. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989). Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84: 1353-1357.
31. Wrase J, Reimold M, Puls I, Kienast T, Heinz A (2006). Serotonergic dysfunction: brain imaging and behavioral correlates. Cogn Affect Behav Neurosci 6: 53-61.
32. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J (2007). Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Genet 16: 2844-2853.
33. Yang BZ, Zhao H, Kranzler HR, Gelernter J (2005). Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genet Epidemiol 28: 302-312.
34. Zhang H, Kranzler HR, Yang BZ, Luo X, Gelernter J (2008). The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 13 : 531-543.